6.05
price down icon7.35%   -0.48
after-market アフターアワーズ: 6.01 -0.04 -0.66%
loading
前日終値:
$6.53
開ける:
$6.175
24時間の取引高:
4.99M
Relative Volume:
2.85
時価総額:
$1.04B
収益:
$25.55M
当期純損益:
$-341.97M
株価収益率:
-2.1607
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
-15.27%
1か月 パフォーマンス:
+3.77%
6か月 パフォーマンス:
+105.08%
1年 パフォーマンス:
-1.47%
1日の値動き範囲:
Value
$6.015
$6.70
1週間の範囲:
Value
$6.015
$7.25
52週間の値動き範囲:
Value
$1.775
$7.64

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
名前
Relay Therapeutics Inc
Name
セクター
Healthcare (1134)
Name
電話
617-370-8837
Name
住所
60 HAMPSHIRE STREET, CAMBRIDGE
Name
職員
197
Name
Twitter
Name
次回の収益日
2025-02-21
Name
最新のSEC提出書
Name
RLAY's Discussions on Twitter

RLAY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RLAY
Relay Therapeutics Inc
6.05 1.13B 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
409.47 105.61B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
657.53 67.99B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
442.70 58.19B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
854.65 52.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.70 39.60B 447.02M -1.18B -906.14M -6.1812

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-04 再開されました Guggenheim Buy
2025-04-17 開始されました Wells Fargo Equal Weight
2024-09-10 再開されました Goldman Buy
2024-09-10 アップグレード Jefferies Hold → Buy
2024-09-10 ダウングレード Oppenheimer Outperform → Perform
2024-05-10 アップグレード Barclays Equal Weight → Overweight
2023-04-20 アップグレード Jefferies Underperform → Hold
2023-04-19 アップグレード Raymond James Outperform → Strong Buy
2023-04-13 開始されました Raymond James Outperform
2023-02-03 開始されました Oppenheimer Outperform
2022-09-30 開始されました Barclays Equal Weight
2022-09-02 開始されました Stifel Buy
2022-06-06 開始されました Jefferies Underperform
2022-02-01 開始されました Berenberg Buy
2021-07-21 開始されました BofA Securities Buy
2020-12-15 繰り返されました H.C. Wainwright Buy
2020-12-08 開始されました JMP Securities Mkt Outperform
2020-11-05 開始されました H.C. Wainwright Buy
2020-08-10 開始されました Cowen Outperform
2020-08-10 開始されました Goldman Buy
2020-08-10 開始されました Guggenheim Buy
2020-08-10 開始されました JP Morgan Neutral
すべてを表示

Relay Therapeutics Inc (RLAY) 最新ニュース

pulisher
01:47 AM

Has Relay Therapeutics Inc. found a price floor2025 Institutional Moves & Daily Stock Momentum Reports - newser.com

01:47 AM
pulisher
Nov 08, 2025

How Relay Therapeutics Inc. stock compares to growth peersJuly 2025 Rallies & Intraday High Probability Alerts - newser.com

Nov 08, 2025
pulisher
Nov 08, 2025

Full technical analysis of Relay Therapeutics Inc. stockMarket Rally & Safe Entry Trade Reports - newser.com

Nov 08, 2025
pulisher
Nov 07, 2025

Wells Fargo Maintains Relay Therapeutics (RLAY) Equal-Weight Recommendation - Nasdaq

Nov 07, 2025
pulisher
Nov 07, 2025

Relay Therapeutics (RLAY) Analyst Rating Update by Wells Fargo | - GuruFocus

Nov 07, 2025
pulisher
Nov 07, 2025

How to use a screener to detect Relay Therapeutics Inc. breakouts2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com

Nov 07, 2025
pulisher
Nov 07, 2025

Relay Therapeutics Trims Costs And Stays Well-Funded - Finimize

Nov 07, 2025
pulisher
Nov 07, 2025

Relay Therapeutics Reports Q3 2025 Financial Progress - TipRanks

Nov 07, 2025
pulisher
Nov 07, 2025

Decoding Relay Therapeutics Inc (RLAY): A Strategic SWOT Insight - GuruFocus

Nov 07, 2025
pulisher
Nov 06, 2025

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 - Investing News Network

Nov 06, 2025
pulisher
Nov 06, 2025

Relay Therapeutics (RLAY) Advances Clinical Trials in Breast Can - GuruFocus

Nov 06, 2025
pulisher
Nov 06, 2025

Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - Investing News Network

Nov 06, 2025
pulisher
Nov 06, 2025

Relay Therapeutics Inc Reports Q3 2025 EPS of -$0.43, Revenue at $0, Missing Estimates - GuruFocus

Nov 06, 2025
pulisher
Nov 06, 2025

Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029 - TradingView

Nov 06, 2025
pulisher
Nov 06, 2025

RLAY: Clinical progress, reduced losses, and strong cash position support operations into 2029 - TradingView

Nov 06, 2025
pulisher
Nov 06, 2025

Relay Therapeutics, Inc. Appoint Board and Committee, Effective November 4, 2025 - MarketScreener

Nov 06, 2025
pulisher
Nov 06, 2025

What machine learning models say about Relay Therapeutics Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Does Relay Therapeutics Inc. show high probability of rebound2025 Sector Review & Precise Swing Trade Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

How to forecast Relay Therapeutics Inc. trends using time series2025 Biggest Moves & Fast Moving Market Watchlists - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Key metrics from Relay Therapeutics Inc.’s quarterly dataMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com

Nov 06, 2025
pulisher
Nov 05, 2025

Is Relay Therapeutics Inc. stock positioned for long term growth2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Is Relay Therapeutics Inc. stock a safe haven assetTrade Volume Report & Accurate Intraday Trading Signals - Fundação Cultural do Pará

Nov 05, 2025
pulisher
Nov 05, 2025

Sanjiv Patel Sells 62,073 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat

Nov 05, 2025
pulisher
Nov 05, 2025

Regression analysis insights on Relay Therapeutics Inc. performanceJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Is Relay Therapeutics Inc. stock a top momentum playTrade Risk Report & Daily Stock Trend Reports - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Published on: 2025-11-05 03:30:55 - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Why hedge funds are buying Relay Therapeutics Inc. stockJuly 2025 Technicals & Safe Capital Growth Plans - newser.com

Nov 05, 2025
pulisher
Nov 04, 2025

Why retail investors favor Relay Therapeutics Inc. stockExit Point & Verified Short-Term Trading Plans - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

Backtesting results for Relay Therapeutics Inc. trading strategiesJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November - Investing News Network

Nov 03, 2025
pulisher
Nov 03, 2025

Relay Therapeutics (NASDAQ: RLAY) to join Guggenheim, Jefferies chats on Nov. 10 & 19 - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 09:01:58 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 01:59:20 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Building trade automation scripts for Relay Therapeutics Inc.2025 Key Lessons & Daily Technical Forecast Reports - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 22:47:47 - newser.com

Nov 02, 2025

Relay Therapeutics Inc (RLAY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$38.56
price down icon 5.44%
$28.66
price down icon 0.62%
$105.98
price up icon 0.70%
$103.14
price down icon 0.20%
biotechnology ONC
$319.97
price down icon 3.73%
$189.70
price up icon 2.17%
大文字化:     |  ボリューム (24 時間):